메뉴 건너뛰기




Volumn 30, Issue 1, 2005, Pages 90-98

Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats

Author keywords

Buprenorphine; CRF; Opiate; Place aversion; Rats; Withdrawal

Indexed keywords

ACAMPROSATE; ANTALARMIN; BUPRENORPHINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; MORPHINE; NALOXONE; SEROTONIN UPTAKE INHIBITOR; TERGURIDE; ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1; DRUG DERIVATIVE; LISURIDE; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; TAURINE;

EID: 11144275200     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300487     Document Type: Article
Times cited : (118)

References (75)
  • 1
    • 0031813519 scopus 로고    scopus 로고
    • Mechanism of action of acamprosate: Part II Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex
    • al Qatari M, Bouchenafa O, Littleton J (1998). Mechanism of action of acamprosate: Part II Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 22: 810-814.
    • (1998) Alcohol Clin Exp Res , vol.22 , pp. 810-814
    • Al Qatari, M.1    Bouchenafa, O.2    Littleton, J.3
  • 2
    • 0027473654 scopus 로고
    • Rapid induction of conditioned opiate withdrawal in the rat
    • Baldwin HA, Koob GF (1993). Rapid induction of conditioned opiate withdrawal in the rat. Neuropsychopharmacology 8: 15-21.
    • (1993) Neuropsychopharmacology , vol.8 , pp. 15-21
    • Baldwin, H.A.1    Koob, G.F.2
  • 3
    • 0021721951 scopus 로고
    • A homotaurine derivative reduces the voluntary intake of ethanol by rats: Are cerebral GABA receptors involved?
    • Boismare F, Daoust M, Moore N, Saligaut C, Lhuintre JP, Chretien P et al (1984). A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav 21: 787-789.
    • (1984) Pharmacol Biochem Behav , vol.21 , pp. 787-789
    • Boismare, F.1    Daoust, M.2    Moore, N.3    Saligaut, C.4    Lhuintre, J.P.5    Chretien, P.6
  • 4
    • 0026714476 scopus 로고
    • Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role
    • Cador M, Ahmed SH, Koob GF, Le Moal M, Stinus L (1992). Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role. Brain Res 597: 304-309.
    • (1992) Brain Res , vol.597 , pp. 304-309
    • Cador, M.1    Ahmed, S.H.2    Koob, G.F.3    Le Moal, M.4    Stinus, L.5
  • 5
    • 0033958458 scopus 로고    scopus 로고
    • Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plusmaze
    • Cole JC, Littleton JM, Little HJ (2000). Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plusmaze. Psychopharmacology 147: 403-411.
    • (2000) Psychopharmacology , vol.147 , pp. 403-411
    • Cole, J.C.1    Littleton, J.M.2    Little, H.J.3
  • 6
    • 0026570222 scopus 로고
    • Buprenorphine and gastrointestinal transit in rats: Effect of naloxone on the biphasic dose-response curve
    • Cowan A (1992). Buprenorphine and gastrointestinal transit in rats: effect of naloxone on the biphasic dose-response curve. Clin Exp Pharmacol Physiol 19: 47-49.
    • (1992) Clin Exp Pharmacol Physiol , vol.19 , pp. 47-49
    • Cowan, A.1
  • 7
    • 0017756322 scopus 로고
    • Agonist and antagonist properties of buprenorphine, a new antinociceptive agent
    • Cowan A, Lewis JW, Macfarlane IR (1977). Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60: 537-545.
    • (1977) Br J Pharmacol , vol.60 , pp. 537-545
    • Cowan, A.1    Lewis, J.W.2    Macfarlane, I.R.3
  • 8
    • 0020510357 scopus 로고
    • Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: An immunohistochemical study
    • Cummings S, Elde R, Ells J, Lindall A (1983). Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3: 1355-1368.
    • (1983) J Neurosci , vol.3 , pp. 1355-1368
    • Cummings, S.1    Elde, R.2    Ells, J.3    Lindall, A.4
  • 9
    • 0032550745 scopus 로고    scopus 로고
    • Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats
    • Dahchour A, De Witte P, Bolo N, Nedelec JF, Muzet M, Durbin P et al (1998). Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82: 107-114.
    • (1998) Psychiatry Res , vol.82 , pp. 107-114
    • Dahchour, A.1    De Witte, P.2    Bolo, N.3    Nedelec, J.F.4    Muzet, M.5    Durbin, P.6
  • 10
    • 0032892569 scopus 로고    scopus 로고
    • The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
    • Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF et al (1999). The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140: 79-86.
    • (1999) Endocrinology , vol.140 , pp. 79-86
    • Deak, T.1    Nguyen, K.T.2    Ehrlich, A.L.3    Watkins, L.R.4    Spencer, R.L.5    Maier, S.F.6
  • 11
    • 0034719355 scopus 로고    scopus 로고
    • Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
    • Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434.
    • (2000) Nature , vol.403 , pp. 430-434
    • Delfs, J.M.1    Zhu, Y.2    Druhan, J.P.3    Aston-Jones, G.4
  • 12
    • 0036429992 scopus 로고    scopus 로고
    • Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal
    • Frenois F, Cador M, Caille S, Stinus L, Le Moine C (2002). Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.
    • (2002) Eur J Neurosci , vol.16 , pp. 1377-1389
    • Frenois, F.1    Cador, M.2    Caille, S.3    Stinus, L.4    Le Moine, C.5
  • 13
    • 0025854386 scopus 로고
    • Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour
    • Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P (1991). Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol 26: 129-137.
    • (1991) Alcohol Alcohol , vol.26 , pp. 129-137
    • Gewiss, M.1    Heidbreder, C.2    Opsomer, L.3    Durbin, P.4    De Witte, P.5
  • 14
    • 0028123538 scopus 로고
    • Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat
    • Gold LH, Stinus L, Inturrisi CE, Koob GF (1994). Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol 253: 45-51.
    • (1994) Eur J Pharmacol , vol.253 , pp. 45-51
    • Gold, L.H.1    Stinus, L.2    Inturrisi, C.E.3    Koob, G.F.4
  • 15
    • 0035204459 scopus 로고    scopus 로고
    • Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion
    • Gracy KN, Dankiewicz LA, Koob GF (2001). Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24: 152-160.
    • (2001) Neuropsychopharmacology , vol.24 , pp. 152-160
    • Gracy, K.N.1    Dankiewicz, L.A.2    Koob, G.F.3
  • 16
    • 0023796363 scopus 로고
    • Aversive properties of opiate receptor blockade: Evidence for exclusively central mediation in naive and morphine-dependent rats
    • Hand TH, Koob GF, Stinus L, Le Moal M (1988). Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 474: 364-368.
    • (1988) Brain Res , vol.474 , pp. 364-368
    • Hand, T.H.1    Koob, G.F.2    Stinus, L.3    Le Moal, M.4
  • 17
    • 0026349239 scopus 로고
    • Both conditioned taste preference and aversion induced by corticotropin-releasing factor
    • Heinrichs SC, Britton KT, Koob GF (1991). Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Pharmacol Biochem Behav 40: 717-721.
    • (1991) Pharmacol Biochem Behav , vol.40 , pp. 717-721
    • Heinrichs, S.C.1    Britton, K.T.2    Koob, G.F.3
  • 18
    • 0028860024 scopus 로고
    • Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal
    • Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L (1995). Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6: 74-80.
    • (1995) Behav Pharmacol , vol.6 , pp. 74-80
    • Heinrichs, S.C.1    Menzaghi, F.2    Schulteis, G.3    Koob, G.F.4    Stinus, L.5
  • 19
    • 0032007883 scopus 로고    scopus 로고
    • Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats
    • Heyser CJ, Schulteis G, Durbin P, Koob GF (1998). Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18: 125-133.
    • (1998) Neuropsychopharmacology , vol.18 , pp. 125-133
    • Heyser, C.J.1    Schulteis, G.2    Durbin, P.3    Koob, G.F.4
  • 20
    • 0343683410 scopus 로고    scopus 로고
    • Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation
    • Holter SM, Landgraf R, Zieglgansberger W, Spanagel R (1997). Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21: 862-868.
    • (1997) Alcohol Clin Exp Res , vol.21 , pp. 862-868
    • Holter, S.M.1    Landgraf, R.2    Zieglgansberger, W.3    Spanagel, R.4
  • 21
    • 0018147760 scopus 로고
    • Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction
    • Jasinski DR, Pevnick JS, Griffith JD (1978). Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry 35: 501-516.
    • (1978) Arch Gen Psychiatry , vol.35 , pp. 501-516
    • Jasinski, D.R.1    Pevnick, J.S.2    Griffith, J.D.3
  • 22
    • 0034565642 scopus 로고    scopus 로고
    • Buprenorphine and naloxone for heroin dependence
    • Johnson RE, McCagh JC (2000). Buprenorphine and naloxone for heroin dependence. Curr Psychiatry Rep 2: 519-526.
    • (2000) Curr Psychiatry Rep , vol.2 , pp. 519-526
    • Johnson, R.E.1    McCagh, J.C.2
  • 23
    • 0033232472 scopus 로고    scopus 로고
    • Corticotropin-releasing factor, norepinephrine and stress
    • Koob GF (1999). Corticotropin-releasing factor, norepinephrine and stress. Biol Psychiatry 46: 1167-1180.
    • (1999) Biol Psychiatry , vol.46 , pp. 1167-1180
    • Koob, G.F.1
  • 24
    • 0033457357 scopus 로고    scopus 로고
    • A role for corticotropin-releasing factor and urocortin in behavioral responses to stressors
    • Koob GF, Heinrichs SC (1999). A role for corticotropin-releasing factor and urocortin in behavioral responses to stressors. Brain Res 848: 141-152.
    • (1999) Brain Res , vol.848 , pp. 141-152
    • Koob, G.F.1    Heinrichs, S.C.2
  • 26
    • 0030756351 scopus 로고    scopus 로고
    • Drug abuse: Hedonic homeostatic dysregulation
    • Koob GF, Le Moal M (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58.
    • (1997) Science , vol.278 , pp. 52-58
    • Koob, G.F.1    Le Moal, M.2
  • 27
    • 0035199891 scopus 로고    scopus 로고
    • Drug addiction, dysregulation of reward, and allostasis
    • Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129.
    • (2001) Neuropsychopharmacology , vol.24 , pp. 97-129
    • Koob, G.F.1    Le Moal, M.2
  • 29
    • 0021322009 scopus 로고
    • Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat
    • Koob GF, Pettit HO, Ettenberg A, Bloom FE (1984). Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J Pharmacol Exp Ther 229: 481-486.
    • (1984) J Pharmacol Exp Ther , vol.229 , pp. 481-486
    • Koob, G.F.1    Pettit, H.O.2    Ettenberg, A.3    Bloom, F.E.4
  • 30
  • 31
    • 0023216221 scopus 로고
    • Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate
    • Le Magnen J, Tran G, Durlach J, Martin C (1987). Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate. Alcohol 4: 97-102.
    • (1987) Alcohol , vol.4 , pp. 97-102
    • Le Magnen, J.1    Tran, G.2    Durlach, J.3    Martin, C.4
  • 32
    • 0027949004 scopus 로고
    • Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF)
    • Lee Y, Schulkin J, Davis M (1994). Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF). Brain Res 666: 93-98.
    • (1994) Brain Res , vol.666 , pp. 93-98
    • Lee, Y.1    Schulkin, J.2    Davis, M.3
  • 33
    • 0026060950 scopus 로고
    • Buprenorphine: Bell-shaped dose-response curve for its antagonist effects
    • Lizasoain I, Leza JC, Lorenzo P (1991). Buprenorphine: bell-shaped dose-response curve for its antagonist effects. Gen Pharmacol 22: 297-300.
    • (1991) Gen Pharmacol , vol.22 , pp. 297-300
    • Lizasoain, I.1    Leza, J.C.2    Lorenzo, P.3
  • 34
    • 0034601448 scopus 로고    scopus 로고
    • Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats
    • Lu L, Ceng X, Huang M (2000a). Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats. NeuroReport 11: 2373-2378.
    • (2000) NeuroReport , vol.11 , pp. 2373-2378
    • Lu, L.1    Ceng, X.2    Huang, M.3
  • 35
    • 0034509832 scopus 로고    scopus 로고
    • Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence
    • Lu L, Liu D, Ceng X, Ma L (2000b). Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur J Neurosci 12: 4398-4404.
    • (2000) Eur J Neurosci , vol.12 , pp. 4398-4404
    • Lu, L.1    Liu, D.2    Ceng, X.3    Ma, L.4
  • 36
    • 0037345745 scopus 로고    scopus 로고
    • Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes
    • Lu L, Liu Z, Huang M, Zhang Z (2003). Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J Neurochem 84: 1378-1386.
    • (2003) J Neurochem , vol.84 , pp. 1378-1386
    • Lu, L.1    Liu, Z.2    Huang, M.3    Zhang, Z.4
  • 38
    • 0034595891 scopus 로고    scopus 로고
    • CRF and urocortin decreased brain stimulation reward in the rat: Reversal by a CRF receptor antagonist
    • Macey DJ, Koob GF, Markou A (2000). CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res 866: 82-91.
    • (2000) Brain Res , vol.866 , pp. 82-91
    • Macey, D.J.1    Koob, G.F.2    Markou, A.3
  • 39
    • 0034816006 scopus 로고    scopus 로고
    • Treatment of alcohol-dependent outpatients with acamprosate: A clinical review
    • Mason BJ (2001). Treatment of alcohol-dependent outpatients with acamprosate: a clinical review. J Clin Psychiatry 62(Suppl 20): 42-48.
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 20 , pp. 42-48
    • Mason, B.J.1
  • 42
    • 0029117641 scopus 로고
    • Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
    • Merlo-Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF et al (1995). Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15: 5439-5447.
    • (1995) J Neurosci , vol.15 , pp. 5439-5447
    • Merlo-Pich, E.1    Lorang, M.2    Yeganeh, M.3    Rodriguez De Fonseca, F.4    Raber, J.5    Koob, G.F.6
  • 43
    • 0031868767 scopus 로고    scopus 로고
    • Mechanism of action of acamprosate: Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain
    • Naassila M, Hammoumi S, Legrand E, Durbin P, Daoust M (1998). Mechanism of action of acamprosate: Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 22: 802-809.
    • (1998) Alcohol Clin Exp Res , vol.22 , pp. 802-809
    • Naassila, M.1    Hammoumi, S.2    Legrand, E.3    Durbin, P.4    Daoust, M.5
  • 44
    • 0034783673 scopus 로고    scopus 로고
    • Dopamine partial agonist reverses amphetamine withdrawal in rats
    • Orsini C, Koob GF, Pulvirenti L (2001). Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25: 789-792.
    • (2001) Neuropsychopharmacology , vol.25 , pp. 789-792
    • Orsini, C.1    Koob, G.F.2    Pulvirenti, L.3
  • 45
    • 0032824985 scopus 로고    scopus 로고
    • Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats
    • Pascucci T, Cioli I, Pisetzky F, Dupre S, Spirito A, Nencini P (1999). Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats. Pharmacol Res 40: 333-338.
    • (1999) Pharmacol Res , vol.40 , pp. 333-338
    • Pascucci, T.1    Cioli, I.2    Pisetzky, F.3    Dupre, S.4    Spirito, A.5    Nencini, P.6
  • 46
    • 0024412883 scopus 로고
    • Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats
    • Porrino LJ, Ritz MC, Goodman NL, Sharpe LG, Kuhar MJ, Goldberg SR (1989). Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 45: 1529-1535.
    • (1989) Life Sci , vol.45 , pp. 1529-1535
    • Porrino, L.J.1    Ritz, M.C.2    Goodman, N.L.3    Sharpe, L.G.4    Kuhar, M.J.5    Goldberg, S.R.6
  • 47
    • 0032159422 scopus 로고    scopus 로고
    • Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat
    • Pulvirenti L, Balducci C, Piercy M, Koob GF (1998). Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. J Pharmacol Exp Ther 286: 1231-1238.
    • (1998) J Pharmacol Exp Ther , vol.286 , pp. 1231-1238
    • Pulvirenti, L.1    Balducci, C.2    Piercy, M.3    Koob, G.F.4
  • 48
    • 0027415929 scopus 로고
    • Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
    • Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993). Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605: 25-32.
    • (1993) Brain Res , vol.605 , pp. 25-32
    • Rassnick, S.1    Heinrichs, S.C.2    Britton, K.T.3    Koob, G.F.4
  • 49
    • 0033563987 scopus 로고    scopus 로고
    • In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats
    • Richter RM, Weiss F (1999). In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32: 254-261.
    • (1999) Synapse , vol.32 , pp. 254-261
    • Richter, R.M.1    Weiss, F.2
  • 50
    • 0039534405 scopus 로고    scopus 로고
    • Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
    • Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276: 2050-2054.
    • (1997) Science , vol.276 , pp. 2050-2054
    • Rodriguez De Fonseca, F.1    Carrera, M.R.A.2    Navarro, M.3    Koob, G.F.4    Weiss, F.5
  • 51
    • 0028907281 scopus 로고
    • Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats
    • Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G (1995). Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res 675: 89-97.
    • (1995) Brain Res , vol.675 , pp. 89-97
    • Sarnyai, Z.1    Biro, E.2    Gardi, J.3    Vecsernyes, M.4    Julesz, J.5    Telegdy, G.6
  • 53
    • 0034729693 scopus 로고    scopus 로고
    • Conditioning and opiate withdrawal: The amygdala links neutral stimuli with the agony of overcoming drug addiction
    • Schulteis G, Ahmed SH, Morse AC, Koob GF, Everitt BJ (2000). Conditioning and opiate withdrawal: the amygdala links neutral stimuli with the agony of overcoming drug addiction. Nature 405: 1013-1014.
    • (2000) Nature , vol.405 , pp. 1013-1014
    • Schulteis, G.1    Ahmed, S.H.2    Morse, A.C.3    Koob, G.F.4    Everitt, B.J.5
  • 54
    • 0030671103 scopus 로고    scopus 로고
    • Preclinical behavioral models for addressing unmet needs in opiate addiction
    • Schulteis G, Gold LH, Koob GF (1997). Preclinical behavioral models for addressing unmet needs in opiate addiction. Semin Neurosci 9: 94-109.
    • (1997) Semin Neurosci , vol.9 , pp. 94-109
    • Schulteis, G.1    Gold, L.H.2    Koob, G.F.3
  • 55
    • 0028125167 scopus 로고
    • Relative sensitivity to naloxone of multiple indices of opiate withdrawal: A quantitative dose-response analysis
    • Schulteis G, Markou A, Gold LH, Stinus L, Koob GF (1994). Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271: 1391-1398.
    • (1994) J Pharmacol Exp Ther , vol.271 , pp. 1391-1398
    • Schulteis, G.1    Markou, A.2    Gold, L.H.3    Stinus, L.4    Koob, G.F.5
  • 56
    • 0031960095 scopus 로고    scopus 로고
    • CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats
    • Shaham Y, Erb S, Leung S, Buczek Y, Stewart J (1998). CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology 137: 184-190.
    • (1998) Psychopharmacology , vol.137 , pp. 184-190
    • Shaham, Y.1    Erb, S.2    Leung, S.3    Buczek, Y.4    Stewart, J.5
  • 57
    • 0030900836 scopus 로고    scopus 로고
    • Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats
    • Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J (1997). Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17: 2605-2614.
    • (1997) J Neurosci , vol.17 , pp. 2605-2614
    • Shaham, Y.1    Funk, D.2    Erb, S.3    Brown, T.J.4    Walker, C.D.5    Stewart, J.6
  • 58
    • 0034646909 scopus 로고    scopus 로고
    • Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior
    • Shepard JD, Barron KW, Myers DA (2000). Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861: 288-295.
    • (2000) Brain Res , vol.861 , pp. 288-295
    • Shepard, J.D.1    Barron, K.W.2    Myers, D.A.3
  • 59
    • 0342281459 scopus 로고    scopus 로고
    • Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
    • Spanagel R, Holter SM, Allingham K, Landgraf R, Zieglgänsberger W (1996a). Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305: 39-44.
    • (1996) Eur J Pharmacol , vol.305 , pp. 39-44
    • Spanagel, R.1    Holter, S.M.2    Allingham, K.3    Landgraf, R.4    Zieglgänsberger, W.5
  • 61
    • 0031697417 scopus 로고    scopus 로고
    • Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress
    • Spanagel R, Sillaber I, Zieglgansberger W, Corrigall WA, Stewart J, Shaham Y (1998). Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology 139: 391-401.
    • (1998) Psychopharmacology , vol.139 , pp. 391-401
    • Spanagel, R.1    Sillaber, I.2    Zieglgansberger, W.3    Corrigall, W.A.4    Stewart, J.5    Shaham, Y.6
  • 62
    • 0031081578 scopus 로고    scopus 로고
    • Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes
    • Spanagel R, Zieglgansberger W (1997). Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18: 54-59.
    • (1997) Trends Pharmacol Sci , vol.18 , pp. 54-59
    • Spanagel, R.1    Zieglgansberger, W.2
  • 63
    • 0034088863 scopus 로고    scopus 로고
    • Opiate withdrawal-induced place aversion lasts for up to 16 weeks
    • Stinus L, Caille S, Koob GF (2000). Opiate withdrawal-induced place aversion lasts for up to 16 weeks. Psychopharmacology 149: 115-120.
    • (2000) Psychopharmacology , vol.149 , pp. 115-120
    • Stinus, L.1    Caille, S.2    Koob, G.F.3
  • 64
    • 0025063449 scopus 로고
    • Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
    • Stinus L, Le Moal M, Koob GF (1990). Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37: 767-773.
    • (1990) Neuroscience , vol.37 , pp. 767-773
    • Stinus, L.1    Le Moal, M.2    Koob, G.F.3
  • 65
    • 0038282996 scopus 로고    scopus 로고
    • Opioid drugs in maintenance and detoxification treatment of opiate addiction: Addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications
    • Substance Abuse Mental Health Services Administration (2002). Opioid drugs in maintenance and detoxification treatment of opiate addiction: addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Federal Register 68: 27937-27939.
    • (2002) Federal Register , vol.68 , pp. 27937-27939
  • 66
    • 0036233866 scopus 로고    scopus 로고
    • Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction
    • Tzschentke TM (2002). Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction. Psychopharmacology 161: 1-16.
    • (2002) Psychopharmacology , vol.161 , pp. 1-16
    • Tzschentke, T.M.1
  • 68
    • 0029070494 scopus 로고
    • Acute administration of buprenorphine in humans: Partial agonist and blockade effects
    • Walsh SL, Preston KL, Bigelow GE, Stitzer ML (1995). Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther 274: 361-372.
    • (1995) J Pharmacol Exp Ther , vol.274 , pp. 361-372
    • Walsh, S.L.1    Preston, K.L.2    Bigelow, G.E.3    Stitzer, M.L.4
  • 69
    • 84873753659 scopus 로고
    • Recent progress in research on the neurophysiologic basis of morphine addiction
    • Wikler A (1948). Recent progress in research on the neurophysiologic basis of morphine addiction. Am J Psychiatry 105: 329-338.
    • (1948) Am J Psychiatry , vol.105 , pp. 329-338
    • Wikler, A.1
  • 70
    • 0015621851 scopus 로고
    • Dynamics of drug dependence: Implications of a conditioning theory for research and treatment
    • Wikler A (1973). Dynamics of drug dependence: implications of a conditioning theory for research and treatment. Arch Gen Psychiatry 28: 611-616.
    • (1973) Arch Gen Psychiatry , vol.28 , pp. 611-616
    • Wikler, A.1
  • 71
    • 0014185083 scopus 로고
    • Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and 'relapse' in morphine-addicted rats
    • Wikler A, Pescor FT (1967). Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and 'relapse' in morphine-addicted rats. Psychopharmacologia 10: 255-284.
    • (1967) Psychopharmacologia , vol.10 , pp. 255-284
    • Wikler, A.1    Pescor, F.T.2
  • 72
    • 0022370868 scopus 로고
    • Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors
    • Wong DT, Reid LR, Bymaster FP, Threlkeld PG (1985). Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J Neural Transm 64: 251-269.
    • (1985) J Neural Transm , vol.64 , pp. 251-269
    • Wong, D.T.1    Reid, L.R.2    Bymaster, F.P.3    Threlkeld, P.G.4
  • 73
    • 0027402518 scopus 로고
    • Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: Possible involvement of excitatory amino acid receptors
    • Zeise ML, Kasparov S, Capogna M, Zieglgansberger W (1993). Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Eur J Pharmacol 231: 47-52.
    • (1993) Eur J Pharmacol , vol.231 , pp. 47-52
    • Zeise, M.L.1    Kasparov, S.2    Capogna, M.3    Zieglgansberger, W.4
  • 74
    • 0034193881 scopus 로고    scopus 로고
    • Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated
    • Zobel AW, Nickel T, Kunzel HE, Ackl N, Sonntag A, Ising M, Holsboer F (2000). Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34: 171-181.
    • (2000) J Psychiatr Res , vol.34 , pp. 171-181
    • Zobel, A.W.1    Nickel, T.2    Kunzel, H.E.3    Ackl, N.4    Sonntag, A.5    Ising, M.6    Holsboer, F.7
  • 75
    • 0037131064 scopus 로고    scopus 로고
    • Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat
    • Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A (2002). Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 952: 188-199.
    • (2002) Brain Res , vol.952 , pp. 188-199
    • Zorrilla, E.P.1    Valdez, G.R.2    Nozulak, J.3    Koob, G.F.4    Markou, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.